Eton Pharmaceuticals, Inc. Business Finance Contracts & Agreements

Asset Purchase Agreement by and among the Company and Dr. Reddys Laboratories S.A., dated as of June 24, 2022 (Filed With SEC on August 11, 2022)

Credit Agreement by and among the Company, the Lenders party thereto, and SWK Funding LLC , as administrative agent dated as of November 13, 2019 and conformed through Third... (Filed With SEC on May 12, 2022)

Underwriting Agreement, dated as of April 8, 2021, by and among Eton Pharmaceuticals, Inc., Harrow Health, Inc. and National Securities Corporation (Filed With SEC on April 8, 2021)

Underwriting Agreement between the Company and National Securities Corporation dated October 14, 2020 (Filed With SEC on October 14, 2020)

Promissory Note between Eton Pharmaceuticals, Inc. and Bank of America, NA (Filed With SEC on May 6, 2020)

Securities Purchase Agreement dated March 26, 2020 by and between the Company and Opaleye L.P (Filed With SEC on March 30, 2020)

Purchase Agreement dated March 26, 2020 by and among the Company and Certain Investors (Filed With SEC on March 30, 2020)

First Amendment to Credit Agreement dated as of March 26, 2020 by and between the Company and SWK Funding LLC, as Agent (Filed With SEC on March 30, 2020)

Warrant dated November 13, 2019 issued to SWK Holdings LLC (Filed With SEC on March 5, 2020)

Credit Agreement dated as of November 13, 2019, by and among the Company and SWK Funding LLC (Filed With SEC on March 5, 2020)

Exclusive License and Product Development Agreement between Eton Pharmaceuticals, Inc. and Aucta Pharmaceuticals, Inc., effective as of July 30, 2019 (but executed as of June 12,... (Filed With SEC on November 14, 2019)

Form of Underwriters Warrant (Filed With SEC on November 5, 2018)

Specimen Certificate representing shares of common stock of Registrant (Filed With SEC on November 5, 2018)

Form of Underwriting Agreement (Filed With SEC on November 5, 2018)

Form of Underwriters Warrant (Filed With SEC on October 31, 2018)

Specimen Certificate representing shares of common stock of Registrant (Filed With SEC on October 31, 2018)

Form of Underwriting Agreement (Filed With SEC on October 31, 2018)

2018 Employee Stock Purchase Plan (Filed With SEC on October 18, 2018)

2018 Employee Stock Purchase Plan (Filed With SEC on September 25, 2018)

Asset Purchase Agreement (DS-200) dated June 23, 2017 between Selenix, LLC and the Registrant (Filed With SEC on August 10, 2018)

Asset Purchase and License Agreement (CT-200) dated May 9, 2017 between Imprimis Pharmaceuticals, Inc. and the Registrant (Filed With SEC on August 10, 2018)

Asset Purchase and License Agreement (CT-100) dated May 9, 2017 between Imprimis Pharmaceuticals, Inc. and the Registrant (Filed With SEC on August 10, 2018)

Registration Rights Agreement dated June 19, 2017 by and among the Registrant and certain of its stockholders (Filed With SEC on August 10, 2018)

Securities Purchase Agreement dated June 19, 2017 by and among the Registrant and the Buyers named therein (Filed With SEC on August 10, 2018)

Warrant dated June 26, 2017 issued to National Securities Corporation (Filed With SEC on August 10, 2018)

Warrant dated May 4, 2017 issued to Liquid Patent Advisors, LLC (Filed With SEC on August 10, 2018)